| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/22/2002 | US20020114764 Tattoo method and system for medical and surgical applications |
| 08/22/2002 | CA2438658A1 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
| 08/22/2002 | CA2427014A1 In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease |
| 08/21/2002 | EP1232255A2 Assay for measuring enzyme activity in vivo |
| 08/21/2002 | EP1232247A2 Modulation of signal transduction |
| 08/21/2002 | EP1231944A2 Targeted delivery of therapeutic and diagnostic moieties |
| 08/21/2002 | CN1365288A Method for detecting and killing epithelial cancer cells |
| 08/20/2002 | US6438398 Process and device for measuring tear fluorescein clearance |
| 08/20/2002 | US6437215 SR-BI and ApoE knockout animals and use thereof as models for atherosclerosis and heart attack |
| 08/20/2002 | US6437141 Cyanine dyes and synthesis methods thereof |
| 08/20/2002 | US6437092 Administering polypeptide with lysine residue derivatized with maleimidopropionic acid; analgesics; narcotic abuse withdrawal |
| 08/20/2002 | US6436682 Isolated substantially purified gaussia, renilla mulleri or pleuromamma luciferase protein encoded by specified nucleotide sequences |
| 08/20/2002 | CA2106573C Debridement of bodily cavities using debridement fluids |
| 08/20/2002 | CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins |
| 08/15/2002 | WO2002062810A2 Linkable sialyl lewis x analogs |
| 08/15/2002 | WO2002062332A1 Pharmaceutical composition for treating multiple sclerosis |
| 08/15/2002 | WO2002004023A3 Photoactivated drug therapy |
| 08/15/2002 | US20020111303 Protein found in breast, prostate gland cells cancer membrane |
| 08/15/2002 | US20020110824 Screening for modulators of dermatitis; obtain tissue sample, incubate with modulator, monitor expression of preferential cytokine, presence of cytokine indicates dermatitis |
| 08/15/2002 | US20020110822 Classification of preferential dermatitus; obtain skin sample, recover nucleotide sequences, monitor expression pattern of cytokine, classify dermatitis |
| 08/15/2002 | US20020110609 Increasing retrievable fluid from a breast duct |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/14/2002 | EP1230935A2 Modified colloids and their use |
| 08/14/2002 | EP0708761B1 Enhanced relaxivity monomeric and multimeric compounds |
| 08/14/2002 | DE10105921A1 An Kolloide gebundene Arzneiwirkstoffe At colloids bound drug targets |
| 08/14/2002 | DE10103506A1 Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose A pharmaceutical composition for the treatment of Multiple Sclerosis |
| 08/14/2002 | CN1364170A Thiophene A2A receptor agaonists |
| 08/14/2002 | CN1089008C In-vivo diagnostic process by near infrared radiation |
| 08/13/2002 | US6433040 Administering nonaqueous suspension in liquid fluorochemical with plurality of perforated microstructures filled with bioactive agent dispersed therin to nose or lungs; drug delivery |
| 08/13/2002 | US6432381 Particulate crystalline drugs with poor water solubility are formulated with a poloxamer and water |
| 08/13/2002 | US6430939 Hyperpolarized gas containers,solenoids, transport and storage devices and associated transport and storage methods |
| 08/08/2002 | WO2002060941A2 Fluorescent proteins |
| 08/08/2002 | WO2002060919A2 Molecules with extended half-lives, compositions and uses thereof |
| 08/08/2002 | WO2002060524A2 Enhanced ultrasound detection with temperature dependent contrast agents |
| 08/08/2002 | WO2002060382A2 Novel compounds and uses thereof |
| 08/08/2002 | WO2001096528A3 Human tumor necrosis factor delta and epsilon |
| 08/08/2002 | WO2001093917A3 Preparation for breast duct fluid collection |
| 08/08/2002 | WO2001090330A3 AMINOACYL tRNA SYNTHETASES |
| 08/08/2002 | WO2001089380A3 Combined impedance imaging and mammography |
| 08/08/2002 | US20020108135 Methods of simulating human prostate cancer progression |
| 08/08/2002 | US20020108131 Screening drugs for use in treatment of heart defects and stroke; obtain animal, incubate with drug, monitor animal for adjustment in phenotype |
| 08/08/2002 | US20020108129 Method for producing anterior ischemic optic neuropathy in animals |
| 08/08/2002 | US20020107437 Subcutaneous cavity marking device and method |
| 08/08/2002 | US20020106328 Contrast agents |
| 08/08/2002 | US20020106327 B/b-like fragment targeting for the purposes of photodynamic therapy and medical imaging |
| 08/08/2002 | US20020106325 Administering to mammal vitronectin receptor targeted imaging agent and a perfusion imaging agent; concurrently detecting vitronectin receptor targeted imaging agent bound at vitronectin receptor and perfusion imaging agent; imaging |
| 08/08/2002 | CA2435395A1 Enhanced ultrasound detection with temperature dependent contrast agents |
| 08/08/2002 | CA2434293A1 Fluorescent proteins |
| 08/07/2002 | EP1228770A1 Lyophilisable contrast agent comprising gas microbubbles |
| 08/07/2002 | EP1228369A1 Method and means for detecting inflammatory processes |
| 08/07/2002 | EP1228217A2 Conserved neisserial antigens |
| 08/07/2002 | EP1228131A1 Radio-opaque molded plastic parts |
| 08/07/2002 | EP1227844A2 Compositions for treating atheroma and neoplastic tissue |
| 08/07/2002 | EP1227841A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 08/07/2002 | EP1227818A2 Abc1 modulation for the modulation of cholesterol transport |
| 08/07/2002 | EP1181352A4 Versican and epithelial-mesenchymal interaction |
| 08/06/2002 | US6428969 Method for determining oncogenic activity of a substance |
| 08/06/2002 | US6428814 Stabilizers prevent aggregation of nanoparticles and increase bioadhesion to substrates such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, and/or plant tissue |
| 08/06/2002 | US6427452 Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers |
| 08/01/2002 | WO2002059323A2 Aminoacyl trna synthetases |
| 08/01/2002 | WO2002059312A2 Cell adhesion proteins |
| 08/01/2002 | WO2002059286A2 Adenylate cyclases |
| 08/01/2002 | WO2002059283A2 Nucleic acid modification enzymes |
| 08/01/2002 | WO2002059097A1 Novel gd(iii) ligands with bi- and bis-azolic structures |
| 08/01/2002 | WO2002058739A2 Orally ingestible baked radiopaque product for testing for dysphagia |
| 08/01/2002 | WO2002058688A1 Use of neurotoxic substances in producing a medicament for treating joint pains |
| 08/01/2002 | WO2002058538A2 Methods of imaging and targeting vasculature |
| 08/01/2002 | WO2002046139A3 1,7 and 1,9-diarylpolymethine salts |
| 08/01/2002 | WO2002036069A3 Hypotension |
| 08/01/2002 | WO2002032285A3 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients |
| 08/01/2002 | WO2002024226A3 Photosensitisers |
| 08/01/2002 | WO2001075110A3 Mucin-1 specific binding members and methods of use thereof |
| 08/01/2002 | US20020104114 Mammalian animal model for use in the evaluation and treatment of brain tumors |
| 08/01/2002 | US20020104108 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 08/01/2002 | US20020102544 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 08/01/2002 | US20020102293 Contrast medium that is to be encapsulated in the liposomes is metered such that 5 to 95% by weight of the contrast medium is present in unencapsulated form stabilization |
| 08/01/2002 | US20020102265 For diagnosis and imaging of cancer and tumor tissues |
| 08/01/2002 | US20020102264 Uses of monoclonal antibody 8H9 |
| 08/01/2002 | US20020102254 For diagnostic and therapeutic uses in cancer |
| 08/01/2002 | US20020102217 For use in ultrasound imaging, contrast agents |
| 08/01/2002 | US20020102216 Enhanced ultrasound detection with temperature-dependent contrast agents |
| 08/01/2002 | US20020102215 Diagnostic/therapeutic agents |
| 08/01/2002 | US20020102214 Paramagnetic material-containing magnetic resonance external marker or calibration composition |
| 08/01/2002 | US20020102212 Providing labeled binding molecules in vivo to tissue having biomolecules; emitting first optical radiation into tissue in vivo to excite labeled binding molecule bound to biomolecule in vivo; and detecting second optical radiation emitted |
| 08/01/2002 | DE10162997A1 Nachweismaterial für auftretende Karies Proof material for caries occurring |
| 08/01/2002 | CA2435418A1 Use of neurotoxic substances in producing a medicament for treating joint pains |
| 08/01/2002 | CA2432134A1 Adenylate cyclases |
| 08/01/2002 | CA2431493A1 Aminoacyl trna synthetases |
| 08/01/2002 | CA2431144A1 Cell adhesion proteins |
| 08/01/2002 | CA2428491A1 Orally ingestible baked radiopaque product for testing for dysphagia |
| 08/01/2002 | CA2427647A1 Nucleic acid modification enzymes |
| 07/31/2002 | EP1226832A2 Preparation of further diagnostic agents |
| 07/31/2002 | EP1226153A2 Fluorescent cobalamins and uses thereof |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/31/2002 | EP1225871A2 Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained |
| 07/31/2002 | EP0810883B1 Conjugate comprising dtpa and albumin for individual medicament dosing |
| 07/31/2002 | EP0808175B1 Contrast media for in vivo imaging based on light transmission or reflection |
| 07/31/2002 | CN1361205A Heavier halogen atom subsituted squa glucoside dye, its producing process and it's used as sensitizing agent in the therapy of optical dynamic and industrial application |
| 07/30/2002 | US6427081 Methods and chemical preparations for time-limited marking of biopsy sites |
| 07/30/2002 | US6426400 Complexes |